Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Abstract

Background Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-aged individuals, their efficacy and safety in elderly people is not fully established. Our aim was to test the benefits of pravastatin treatment in an elderly cohort of men and women with, or at high risk of developing, cardiovascular disease and stroke. Methods We did a randomised controlled trial in which we assigned 5804 men (n=2804) and women (n=3000) aged 70-82 years with a history of, or risk factors for, vascular disease to pravastatin (40 mg per day; n=2891) or placebo (n=2913). Baseline cholesterol concentrations ranged from 4.0 mmol/L to 9.0 mmol/L. Follow-up was 3.2 years on average and our primary endpoint was a composite of coronary death, non-fatal myocardial infarction, and fatal or non-fatal stroke. Analysis was by intention-to-treat. Findings Pravastatin lowered LDL cholesterol concentrations by 34% and reduced the incidence of the primary endpoint to 408 events compared with 473 on placebo (hazard ratio 0.85, 95% CI 0.74-0.97, p=0.014). Coronary heart disease death and non-fatal myocardial infarction risk was also reduced (0.81, 0.69-0.94, p=0.006). Stroke risk was unaffected (1.03, 0.81-1.31, p=0.8), but the hazard ratio for transient ischaemic attack was 0.75 (0.55-1.00, p=0.051). New cancer diagnoses were more frequent on pravastatin than on placebo (1.25, 1.04-1.51, p=0.020). However, incorporation of this finding in a meta-analysis of all pravastatin and a…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)11600-x

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

11 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. Keech, 1992, Does cholesterol lowering reduce total mortality?, Postgrad Med J, 68, 870

Cited by

See all 3,378

Metadata

Authors
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., Kamper, A. M., Macfarlane, P. W., Meinders, A. E., Norrie, J., Packard, C. J., Perry, I. J., Stott, D. J., Sweeney, B. J., Twomey, G., & Westendorp, R. G.
Affiliations
  • Glasgow Royal Infirmary (GB)
  • Leiden University Medical Center (NL)
  • Cork University Hospital (IE)
  • Leiden University (NL)
  • University of Glasgow (GB)
  • University College Cork (IE)
Corresponding author
Shepherd, James
Venue
The Lancet
Publisher
Elsevier BV
Published
2002-11
Volume
360
Issue
9346
Pages
1623-1630
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2135631433
Cited by
3,378
References
31
Citations by year
2026: 41 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 77 · 2021: 78 · 2020: 89 · 2019: 104 · 2018: 101 · 2017: 113 · 2016: 114 · 2015: 140 · 2014: 148 · 2013: 163 · 2012: 140
FWCI
184.25
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
pravastatin, statins, older adults, cardiovascular disease, stroke, myocardial infarction, coronary artery disease, LDL cholesterol, transient ischemic attack, cancer risk, cognitive function, vascular disease
MeSH terms
Aged, Aged, 80 and over, Anticholesteremic Agents, Coronary Artery Disease, Female, Humans, Cholesterol, LDL, Male, Risk Factors, Pravastatin, Endpoint Determination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(02)11600-x
The paper
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., Kamper, A. M., Macfarlane, P. W., Meinders, A. E., Norrie, J., Packard, C. J., Perry, I. J., Stott, D. J., Sweeney, B. J., Twomey, G., & Westendorp, R. G. (2002). Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(02)11600-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.